Millennium Management’s Immune Design Corp. IMDZ Stock Holding History

Millennium Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-80,794	Closed	-$105K	–	4586
2018 Q4	$105K	Buy	80,794 +70,193	+662%	+$122K	﹤0.01%	3536
2018 Q3	$37K	Sell	10,601 -5,500	-34%	-$20.6K	﹤0.01%	3812
2018 Q2	$73K	Sell	16,101 -2,200	-12%	-$8.76K	﹤0.01%	3680
2018 Q1	$60K	Buy	+18,301	New	+$64.8K	﹤0.01%	3525
2017 Q3	–	Sell	-144,534	Closed	-$1.41M	–	4174
2017 Q2	$1.41M	Sell	144,534 -10,211	-7%	-$71.7K	﹤0.01%	2276
2017 Q1	$1.05M	Sell	154,745 -4,745	-3%	-$27.4K	﹤0.01%	2367
2016 Q4	$877K	Buy	159,490 +136,451	+592%	+$964K	﹤0.01%	2323
2016 Q3	$175K	Sell	23,039 -24,896	-52%	-$182K	﹤0.01%	3012
2016 Q2	$391K	Buy	+47,935	New	+$598K	﹤0.01%	2604
2015 Q1	–	Sell	-8,468	Closed	-$261K	–	4576
2014 Q4	$261K	Buy	+8,468	New	+$235K	﹤0.01%	3447

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Millennium Management's IMDZ Position: Q1 2019 in Review

Millennium Management sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 80,794 shares — an estimated $105K sold.

Millennium Management first reported a position in IMDZ in Q4 2014 and held it in 10 quarters. The position peaked at $1.41M in Q2 2017. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

Millennium Management reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
Millennium Management sold 80,794 Immune Design Corp. shares in Q1 2019, an estimated $105K.
Millennium Management first reported a position in Immune Design Corp. in Q4 2014 and held it in 10 quarters.
Millennium Management's Immune Design Corp. position peaked at $1.41M in Q2 2017.
68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.